Why Taysha Gene Therapies's Stock is Trading Higher Today

The Price And Volume Action In Taysha Gene Therapies's Stock Today

Taysha Gene Therapies's TSHA stock is trading up 18.73% to a price of $25.74. The stock's current volume for the day is 258.38 thousand, which is approximately 286.81% of its previous 30-day average volume of 90.09 thousand.

Why It's Moving

Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: Taysha Gene Therapies shares are trading higher after the company announced the acquisition of exclusive worldwide rights to a clinical-stage AAV9 gene therapy program, now known as TSHA-120, for the treatment of giant axonal neuropathy.

Perspective On Recent Price Action

The stock's 50-day moving average was $25.67 at the time this article was published. Over the past fifty-two weeks, the price has risen as high as $33.35 and fallen to a low of $18.16.

If you're looking for timely and concise explanations of why a stock is moving, check out Benzinga Pro. Subscribers get ‘Why Is It Moving' alerts as soon as our research team identifies the cause of the price action in a stock. Click here to learn more.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MoversTrading IdeasBZI-WIIM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!